Artelo Biosciences ARTL
NASDAQ ARTL
$2.18 +0.02 (+0.93%)
At close: Nov 11, 2026 · 4:00 PM EST

Artelo Biosciences (ARTL) Accumulated Expenses (2017 - 2026)

Updated

Artelo Biosciences (ARTL) reported Accumulated Expenses of $26,000 for Q1 2026, up 136.4% from the prior quarter.

Analysis

Artelo Biosciences (ARTL) Accumulated Expenses (2017 - 2026) Analysis & Trends

At the end of FY2025, Artelo Biosciences posted Accumulated Expenses of $11,000.

  • Five-year quarterly Accumulated Expenses spans a low of $11,000 in Q4 2025 and a high of $46,000 in Q3 2025.
  • Per Business Quant data, the three quarters before Q1 2026 came in at $11,000 (Q4 2025), $46,000 (Q3 2025) and $18,000 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Artelo Biosciences 49.32 Mn 32.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 26,000.00
Dec 31, 2025 11,000.00
Sep 30, 2025 46,000.00
Jun 30, 2025 18,000.00
May 31, 2017 1,603.00
Feb 28, 2017 847.00
API Access

Artelo Biosciences Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ARTL&period=max&api_key=YOUR_API_KEY